Cipla Share Price: Stock Analysis, History, and Forecast

The stock market is almost always brimming with possibilities. But picking the best one is a difficult task. Pharmaceutical stocks are an example of such stock on the market. Out of the numerous pharmaceutical stocks on the market, Cipla Share is at the top of the list owing to its  fundamentally sound foundation and robust balance sheets. The Cipla stock market has a track record of USFDA approval and top-notch management.

Furthermore, since the pandemic, the price of Cipla stocks has been steadily rising and continues to do so even today. Cipla can assist investors in growing fruits from their long-term investments in pharmaceutical firms.

If you wish to invest in Cipla’s stock, you should be aware of the current Cipla share price, the price history of Cipla’s stock, and the Cipla share price target for 2022. By compiling all of the information in this write-up, we’ve made it easier for you to find it all in a single blog.

Cipla Share Price Today

The price of Cipla Stock has seen a lot of ups and downs since it entered the stock market. The below table comprehensively showcases the  performance and Cipla Share Price today:

Note: The above data is mentioned as per the Cipla share price today (as per 7th March 2022).

Cipla Share Price NSE

• Live Cipla Share Price NSE India: ₹ 930.20
• Previous Closing Price: ₹ 931.20
• Open Price: ₹ 921.90
• High: ₹ 917.50

Cipla Share Price BSE

• Live Cipla Share Price BSE India: ₹ 926.35
• Previous Closing Price: ₹ 932.00
• Open Price: ₹ 914.95
• High: ₹ 931.00
• Low: ₹ 914.95

Cipla Historical Share Price

Cipla Share Price has seen a lot of changes in the past years. Here is the Cipla stock data from January 2018 to January 2022.

Cipla Company Information

Cipla Limited or Cipla is an Indian-based multinational pharmaceutical company founded in the year 1935. The company is majorly into developing medications for respiratory problems, arthritis, cardiovascular issues, depression, weight control, and diabetes.

Cipla Limited is headquartered in Mumbai and has a market valuation of about ₹560 billion. The company is the 42nd largest company that has been publicly traded as per its market valuation. Cipla deals into the following segments:

• Pharmaceuticals: The pharmaceutical segment of Cipla deals with research, development, manufacturing as well as distribution of branded generic or generic medications. It also deals with API (Active Pharmaceuticals Ingredients) research, development, manufacturing, and distribution.
• New Ventures:  The new venture segment deals with the operational part of the company. Biosimilars, consumer healthcare, and specialty business are its forte.

The product portfolio of Cipla includes complex generics, drugs for respiratory concerns, cardiology, urology, anti-infectives, cardiology, central nervous system (CNS), and antiretrovirals. Ever since its inception, the pharmaceutical company has expanded across multiple countries worldwide, including India, South Africa, and the United States of America (USA).

Management of Cipla

Cipla is a pharmaceutical company that has some of the best management processes in the country and around the world. The table below shows the list of management members of the company.

Cipla Share Market Shareholding Pattern

The below depicted shareholding pattern is as per the Cipla Pharma Share Price Market of December 2021.

Don’t miss it!

Cipla Limited Company Location

Cipla is headquartered in Mumbai, Maharashtra. Check out the address and other contact details below

• Headquarter Address: Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
• Contact Numbers: +91 22 24826000 / +91 22 24826300
• Fax Number: +91 22 24826120
• E-mail ID: contactus@cipla[dot]com

Cipla Share’s Background

• Industry Name: Pharma – Indian
• House Name: Cipla Group
• Incorporation Date: 17/08/1935     
• Face Value: 2.0
• ISIN: INE059A01026
• Market Lot: 1

Cipla Company Performance

Take a look at Cipla’s performance from March 2017 to 2021 in the below table.

Cipla Limited Stock Returns in 2020 and 2021

Here’s a detailed list of the stock returns of Cipla limited for 2020 and 2021.

Summary of Cipla Share Price in 2020 and 2021

Given below is an overview of Cipla Share Price for the years 2020 and 2021.

• Highest: ₹ 1,005.00
• Lowest: ₹ 354.38
• Difference: ₹ 650.62
• Average: ₹ 775.32
• Chg. %: 97.94

Cipla Limited Listings and Indices

Check out Cipla’s listing and indices information below.  

Key Dates

• Incorporation Date: 17/08/1935
• Year Ending Month: March
• AGM Month: August
• Book Closure Start Date: 11/08/2021
• Book Closure End Date: 25/08/2021

Listing Information

• Face Value: 2.0
• Market Lot Of Equity Shares: 1
• BSE Code: 500087
• BSE Group: A

Cipla Stock Indices

Cipla Pharma Share forms a part of the following indices:

• MCX-SX 40 Index
• NIFTY 100
• NIFTY 100 Low Volatility 30
• NIFTY 200
• NIFTY 50
• NIFTY 50 Equal Weight
• NIFTY 500
• NIFTY 500 Multicap 50:25:25 Index
• NIFTY Alpha 50
• NIFTY Alpha Low Volatility 30
• NIFTY Growth Sectors 15
• NIFTY Healthcare Index
• NIFTY India Manufacturing Index
• NIFTY LargeMidcap 250
• NIFTY Low Volatility 50
• NIFTY Pharma
• NIFTY100 Equal Weight
• NIFTY200 Momentum 30 Index
• NIFTY50 USD
• S&P BSE 100
• S&P BSE 100 ESG Index
• S&P BSE 100 LargeCap TMC Index
• S&P BSE 200
• S&P BSE 250 LargeMidCap Index
• S&P BSE 500
• S&P BSE AllCap
• S&P BSE Carbonex
• S&P BSE Dividend Stability Index
• S&P BSE Dollex – 100
• S&P BSE Dollex – 200
• S&P BSE Dollex – 30
• S&P BSE Greenex
• S&P BSE Healthcare
• S&P BSE India Manufacturing
• S&P BSE LargeCap
• S&P BSE LargeMidCap
• S&P BSE Sensex 50
• S&P BSE TASIS Shariah 50

Company Listed On

Cipla is also listed on the following:

• Bangalore Stock Exchange Ltd.
• Calcutta Stock Exchange Association Ltd.
• Cochin Stock Exchange Ltd.
• Delhi Stock Exchange Assoc. Ltd.
• Hyderabad Stock Exchange Ltd
• Ludhiana Stock Exchange Assoc. Ltd.
• Madras Stock Exchange Ltd.,
• MCX Stock Exchange
• National Stock Exchange of India Ltd.
• Over The Counter Exchange Of India Ltd.
• The Stock Exchange, Mumbai
• Uttar Pradesh Exchange Assoc Ltd.

Should You Invest in Cipla Limited?

Cipla is a blue chip company, which means that the downside is typically shielded in blue chip stocks, i.e., these firms perform well in most circumstances and their share prices do not decrease dramatically.

However, if you are looking for high profits, this investment may not be for you because these firms do not develop fast owing to their big size and, therefore, are not growth stocks. However, if you are looking for secure stock investments, then Cipla can be a smart choice.

As for the pharmaceutical company, Cipla limited share price has risen 28 per cent since its YTD low in mid-March 2021. The stock movement appears to have been sparked by the USFDA’s approval of the company’s generic Sumatriptan nasal spray in early March.

Positive advances in the company’s engagement with overseas pharma firms for marketing, distribution, and/or production of COVID-related medications are also believed to have contributed to the gain.

At CMP, Cipla is a solid investment opportunity. Long-term investors should consider Cipla stock. It’s a pricey selection at ₹ 965, but it’s a good one. The Cipla stock’s target price is ₹ 1,205. It has a strong yearly return on investment (ROI) of 13 per cent.

Perched at the top of the industry, Cipla is India’s largest pharmaceutical corporation. Hence, the Cipla limited share is a good long-term investment plan to get the best ROI.

FAQ’s about Cipla Share Price